These findings shed light on the dynamics of BCR/TCR repertoire diversity in patients with B-ALL and its association with clinical features, providing valuable insights into the immune landscape of this disease. The gene discussed is BCR; the disease is precursor B-cell acute lymphoblastic leukemia.